A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease

Objective: To assess the cost-effectiveness of nebulized budesonide and intravenous methylprednisolone in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a real-world setting. Materials and methods: Data from 291 patients with AECOPD were collected from the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yong-Li, Sun, Zeng-Xian, Sun, Ying, Wen, Yan, Guan, Xin, Jiang, Dao-Li, Cheng, Cong, Gu, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514722/
https://www.ncbi.nlm.nih.gov/pubmed/36176448
http://dx.doi.org/10.3389/fphar.2022.892526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514722/
https://www.ncbi.nlm.nih.gov/pubmed/36176448
http://dx.doi.org/10.3389/fphar.2022.892526

Ejemplares similares